Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
ClinicalTrials.gov study NCT04205630. IPD Sharing: NO. Countries: 7. Publications: 0.
Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02481050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00121836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor P
ClinicalTrials.gov study NCT02258464. IPD Sharing: Not stated. Countries: 20. Publications: 0.
Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00777049. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breas
ClinicalTrials.gov study NCT04060862. IPD Sharing: NO. Countries: 8. Publications: 0.
Durvalumab with Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
ClinicalTrials.gov study NCT03820141. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT00580333. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
ClinicalTrials.gov study NCT01301729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT02632045. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer
ClinicalTrials.gov study NCT04957212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT01461057. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
ClinicalTrials.gov study NCT02389764. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT05954143. IPD Sharing: NO. Countries: 2. Publications: 0.
Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer
ClinicalTrials.gov study NCT04249440. IPD Sharing: NO. Countries: 0. Publications: 1.
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02658084. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00425854. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00885755. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
ClinicalTrials.gov study NCT02681562. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors
ClinicalTrials.gov study NCT06027983. IPD Sharing: NO. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.